Abstract
A 61-year-old-male with local advanced inoperable cervical esophageal cancer (squamous cell carcinoma, T4N1M0 stage III) was treated by concurrent radiochemotherapy. A dose of 50.6 Gy/46 Fr/36 days and one course each of CDDP-5-FU and nedaplatin-5-FU were delivered safely. Radical surgery could be performed thereafter because of the good tumor response. Pathological CR was obtained in metastatic cervical lymph nodes and almost total necrosis in primary cancer. Concurrent radiochemotherapy produced a significant improvement in this case of advanced cervical esophageal cancer.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Squamous Cell / drug therapy
-
Carcinoma, Squamous Cell / radiotherapy*
-
Carcinoma, Squamous Cell / surgery
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Esophageal Neoplasms / drug therapy
-
Esophageal Neoplasms / radiotherapy*
-
Esophageal Neoplasms / surgery
-
Esophagectomy
-
Fluorouracil / administration & dosage
-
Humans
-
Lymph Nodes / pathology
-
Male
-
Middle Aged
-
Organoplatinum Compounds / administration & dosage
-
Radiotherapy, High-Energy
Substances
-
Organoplatinum Compounds
-
nedaplatin
-
Cisplatin
-
Fluorouracil